Early Use of Remdesivir and Risk of Disease Progression in Hospitalized Patients With Mild to Moderate COVID-19
Clinical Therapeutics(2022)
Abstract
•Remdesivir confers benefit in COVID-19 patients according to the onset of symptoms.•Early hospitalization may be crucial to improve patients outcome.•Alarming symptoms at home should be evaluated to decide hospital admission.
MoreTranslated text
Key words
COVID-19,COVID-19 progression,early treatment,remdesivir,SARS CoV-2
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined